News & Alerts

Statement of the National Breast Cancer Coalition on President & Dr. Biden’s Cancer Moonshot

February 3, 2022

The National Breast Cancer Coalition (NBCC) congratulates President & Dr. Biden on the reignition of the Cancer Moonshot program. NBCC was pleased to be part of yesterday’s White House event. We share the goal of ending cancer, specifically breast cancer, as we know it. We look forward to working with the Administration to make this a reality. 

Importantly, we know that it is not just more money for more research that will get us to this urgent goal. Instead, it is strategic funding for genuinely innovative research and access to affordable treatments that actually saves lives and makes a difference. 

We believe we must see transformational change in three strategic areas: research, access, and influence to end cancer. 

  • Research: Facilitate collaborations in all areas of cancer research and minimize unnecessary competition. 
  • Access: Individuals with and at risk of cancer have access to information, quality care, and scientific advances. 
  • Influence: We must change the national conversation and mobilize all aspects of the cancer advocacy community. 

“We applaud the Biden Administration for taking a whole of government approach to envision an end to cancer as we know it,” said Fran Visco, President of the National Breast Cancer Coalition (NBCC). “NBCC is ready to get to work with you to make it a reality.” 

About NBCC: 

The National Breast Cancer Coalition is a collaboration of activists, survivors, researchers, grassroots groups, and national organizations that have come together as disruptive innovators for social change. NBCC links hundreds of organizations and tens of thousands of individuals from across the country into a dynamic, diverse coalition that gives breast cancer a meaningful voice in Washington, DC, and state capitals, in laboratories and health care institutions, and local communities everywhere. NBCC increases funding and leads efforts for innovative breast cancer research; monitors how research funds are spent; expands access to quality health care for all; and ensures that trained advocates influence all decision-making in breast cancer.